Organization · Venture Capital
Fåhraeus Startup & Growth
Fåhraeus Startup & Growth (FSG) is a venture capital fund based in Lund, Sweden, focusing on early-stage investments in the life science and technology sectors, particularly in the Nordic region.
Overview
What Fåhraeus Startup & Growth does
What Fåhraeus Startup & Growth is
Fåhraeus Startup & Growth (FSG) is a venture capital fund based in Lund, Sweden, focusing on early-stage investments in the life science and technology sectors, particularly in the Nordic region.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder
- Last reviewed
- March 30, 2026
Official channels
Find Fåhraeus Startup & Growth elsewhere
Open the official website or a supported primary organization account.
Capability profile
Fåhraeus Startup & Growth as a funder
Investment thesis
Fåhraeus Startup & Growth invests in early-stage deep tech and life science companies in the Nordic region, focusing on diagnostics, pharmaceuticals, and sustainability tech.
Focus narrative
Fåhraeus Startup & Growth focuses on investing in early-stage startups that are developing groundbreaking solutions in life sciences and technology. The fund emphasizes sectors such as diagnostics and pharmaceuticals, targeting companies that demonstrate commercial traction and innovative approaches to address significant challenges.
Value beyond capital
Fåhraeus Startup & Growth provides significant value to its portfolio companies through access to a vast network of industry contacts, strategic guidance from experienced partners, and support in navigating the complexities of the life science and technology sectors. The fund's deep expertise in diagnostics and pharmaceuticals enhances its ability to assist startups in achieving their growth objectives.
Terms and economics
- Typical check
- $100,000–$5,000,000
- Sweet spot
- $1,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 6
Portfolio context
Notable portfolio companies include: Airsonett: A medical device designed for effective home treatment of allergic asthma and eczema, utilizing patented TLA treatment to provide 99.5% clean air in the breathing zone. Yazen: A digital platform aimed at addressing overweight and obesity, offering tools and support for individuals to achieve and maintain a healthy weight. Next Generation Laser-Based Gas Analysis: This company delivers advanced laser diode gas analyzers capable of detecting even the smallest traces of gas in real-time, even under challenging conditions.
Common questions
What to know about Fåhraeus Startup & Growth
Upseed classifies Fåhraeus Startup & Growth under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.